特発性頭蓋内高血圧症治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Idiopathic Intracranial Hypertension Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03656 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、特発性頭蓋内高血圧症治療の世界市場について調査・分析し、特発性頭蓋内高血圧症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アセタゾールアミド、メタゾールアミド、フロセミド、トピラメート、その他）、用途別（病院、診療所、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の特発性頭蓋内高血圧症治療市場動向 ・主要企業別マーケットシェア ・特発性頭蓋内高血圧症治療の種類別市場規模2014-2019 （アセタゾールアミド、メタゾールアミド、フロセミド、トピラメート、その他） ・特発性頭蓋内高血圧症治療の用途別市場規模2014-2019 （病院、診療所、外来手術センター） ・特発性頭蓋内高血圧症治療の北米市場：主要企業・種類別/用途別市場規模 ・特発性頭蓋内高血圧症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・特発性頭蓋内高血圧症治療の中国市場：主要企業・種類別/用途別市場規模 ・特発性頭蓋内高血圧症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・特発性頭蓋内高血圧症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・特発性頭蓋内高血圧症治療のインド市場：主要企業・種類別/用途別市場規模 ・特発性頭蓋内高血圧症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Avkare, Inc、FDC、Heritage Pharmaceuticals Inc、Ingenus Pharmaceuticals、Janssen - Cilag Pharmaceuticals SA、Lannett Company,、Medtronic、MercuryPharma、Nostrum Laboratories Inc、Novast Holdings Ltd.、Sanofi、SGPharma Pvt. Ltd.、Sophysa、Taro Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd、West-Ward Pharmaceutical、Zydus Pharmaceuticals） ・特発性頭蓋内高血圧症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Idiopathic intracranial hypertension is characterized by a buildup of the cerebrospinal fluid causing increase in the blood volume in vessels surrounding the brain and increase in brain swelling. The increase in salt intake causes water retention in the body together with fat adding on to the calories thereby hindering the weight loss usually advised. Intracranial hypertension can also cause problem with body temperature control when there is overexposure to the sun and its heat.In 2018, the global Idiopathic Intracranial Hypertension Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Idiopathic Intracranial Hypertension Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Idiopathic Intracranial Hypertension Treatment development in United States, Europe and China.

The key players covered in this study
Avkare, Inc
FDC
Heritage Pharmaceuticals Inc
Ingenus Pharmaceuticals
Janssen – Cilag Pharmaceuticals SA
Lannett Company,
Medtronic
MercuryPharma
Nostrum Laboratories Inc
Novast Holdings Ltd.
Sanofi
SGPharma Pvt. Ltd.
Sophysa
Taro Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd
West-Ward Pharmaceutical
Zydus Pharmaceuticals

Market segment by Type, the product can be split into
Acetazolamide
Methazolamide
Furosemide
Topiramate
Others

Market segment by Application, split into
Hospital
Clinics
Ambulatory Surgery Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Idiopathic Intracranial Hypertension Treatment status, future forecast, growth opportunity, key market and key players.
To present the Idiopathic Intracranial Hypertension Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Idiopathic Intracranial Hypertension Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Idiopathic Intracranial Hypertension Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Acetazolamide
1.4.3 Methazolamide
1.4.4 Furosemide
1.4.5 Topiramate
1.4.6 Others
1.5 Market by Application
1.5.1 Global Idiopathic Intracranial Hypertension Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Ambulatory Surgery Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Idiopathic Intracranial Hypertension Treatment Market Size
2.2 Idiopathic Intracranial Hypertension Treatment Growth Trends by Regions
2.2.1 Idiopathic Intracranial Hypertension Treatment Market Size by Regions (2014-2025)
2.2.2 Idiopathic Intracranial Hypertension Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Idiopathic Intracranial Hypertension Treatment Market Size by Manufacturers
3.1.1 Global Idiopathic Intracranial Hypertension Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Idiopathic Intracranial Hypertension Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Idiopathic Intracranial Hypertension Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Idiopathic Intracranial Hypertension Treatment Key Players Head office and Area Served
3.3 Key Players Idiopathic Intracranial Hypertension Treatment Product/Solution/Service
3.4 Date of Enter into Idiopathic Intracranial Hypertension Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-2019)
4.2 Global Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Idiopathic Intracranial Hypertension Treatment Market Size (2014-2019)
5.2 Idiopathic Intracranial Hypertension Treatment Key Players in United States
5.3 United States Idiopathic Intracranial Hypertension Treatment Market Size by Type
5.4 United States Idiopathic Intracranial Hypertension Treatment Market Size by Application

6 Europe
6.1 Europe Idiopathic Intracranial Hypertension Treatment Market Size (2014-2019)
6.2 Idiopathic Intracranial Hypertension Treatment Key Players in Europe
6.3 Europe Idiopathic Intracranial Hypertension Treatment Market Size by Type
6.4 Europe Idiopathic Intracranial Hypertension Treatment Market Size by Application

7 China
7.1 China Idiopathic Intracranial Hypertension Treatment Market Size (2014-2019)
7.2 Idiopathic Intracranial Hypertension Treatment Key Players in China
7.3 China Idiopathic Intracranial Hypertension Treatment Market Size by Type
7.4 China Idiopathic Intracranial Hypertension Treatment Market Size by Application

8 Japan
8.1 Japan Idiopathic Intracranial Hypertension Treatment Market Size (2014-2019)
8.2 Idiopathic Intracranial Hypertension Treatment Key Players in Japan
8.3 Japan Idiopathic Intracranial Hypertension Treatment Market Size by Type
8.4 Japan Idiopathic Intracranial Hypertension Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size (2014-2019)
9.2 Idiopathic Intracranial Hypertension Treatment Key Players in Southeast Asia
9.3 Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Type
9.4 Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Application

10 India
10.1 India Idiopathic Intracranial Hypertension Treatment Market Size (2014-2019)
10.2 Idiopathic Intracranial Hypertension Treatment Key Players in India
10.3 India Idiopathic Intracranial Hypertension Treatment Market Size by Type
10.4 India Idiopathic Intracranial Hypertension Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Idiopathic Intracranial Hypertension Treatment Market Size (2014-2019)
11.2 Idiopathic Intracranial Hypertension Treatment Key Players in Central & South America
11.3 Central & South America Idiopathic Intracranial Hypertension Treatment Market Size by Type
11.4 Central & South America Idiopathic Intracranial Hypertension Treatment Market Size by Application

12 International Players Profiles
12.1 Avkare, Inc
12.1.1 Avkare, Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.1.4 Avkare, Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.1.5 Avkare, Inc Recent Development
12.2 FDC
12.2.1 FDC Company Details
12.2.2 Company Description and Business Overview
12.2.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.2.4 FDC Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.2.5 FDC Recent Development
12.3 Heritage Pharmaceuticals Inc
12.3.1 Heritage Pharmaceuticals Inc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.3.4 Heritage Pharmaceuticals Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.3.5 Heritage Pharmaceuticals Inc Recent Development
12.4 Ingenus Pharmaceuticals
12.4.1 Ingenus Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.4.4 Ingenus Pharmaceuticals Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.4.5 Ingenus Pharmaceuticals Recent Development
12.5 Janssen – Cilag Pharmaceuticals SA
12.5.1 Janssen – Cilag Pharmaceuticals SA Company Details
12.5.2 Company Description and Business Overview
12.5.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.5.4 Janssen – Cilag Pharmaceuticals SA Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.5.5 Janssen – Cilag Pharmaceuticals SA Recent Development
12.6 Lannett Company,
12.6.1 Lannett Company, Company Details
12.6.2 Company Description and Business Overview
12.6.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.6.4 Lannett Company, Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.6.5 Lannett Company, Recent Development
12.7 Medtronic
12.7.1 Medtronic Company Details
12.7.2 Company Description and Business Overview
12.7.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.7.4 Medtronic Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.7.5 Medtronic Recent Development
12.8 MercuryPharma
12.8.1 MercuryPharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.8.4 MercuryPharma Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.8.5 MercuryPharma Recent Development
12.9 Nostrum Laboratories Inc
12.9.1 Nostrum Laboratories Inc Company Details
12.9.2 Company Description and Business Overview
12.9.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.9.4 Nostrum Laboratories Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.9.5 Nostrum Laboratories Inc Recent Development
12.10 Novast Holdings Ltd.
12.10.1 Novast Holdings Ltd. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Idiopathic Intracranial Hypertension Treatment Introduction
12.10.4 Novast Holdings Ltd. Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
12.10.5 Novast Holdings Ltd. Recent Development
12.11 Sanofi
12.12 SGPharma Pvt. Ltd.
12.13 Sophysa
12.14 Taro Pharmaceutical Industries Ltd.
12.15 Teva Pharmaceutical Industries Ltd
12.16 West-Ward Pharmaceutical
12.17 Zydus Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Idiopathic Intracranial Hypertension Treatment Key Market Segments
Table Key Players Idiopathic Intracranial Hypertension Treatment Covered
Table Global Idiopathic Intracranial Hypertension Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size Market Share by Type 2014-2025
Figure Acetazolamide Figures
Table Key Players of Acetazolamide
Figure Methazolamide Figures
Table Key Players of Methazolamide
Figure Furosemide Figures
Table Key Players of Furosemide
Figure Topiramate Figures
Table Key Players of Topiramate
Figure Others Figures
Table Key Players of Others
Table Global Idiopathic Intracranial Hypertension Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgery Centers Case Studies
Figure Idiopathic Intracranial Hypertension Treatment Report Years Considered
Table Global Idiopathic Intracranial Hypertension Treatment Market Size 2014-2025 (Million US$)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Idiopathic Intracranial Hypertension Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Idiopathic Intracranial Hypertension Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Idiopathic Intracranial Hypertension Treatment Market Share by Regions 2014-2019
Figure Global Idiopathic Intracranial Hypertension Treatment Market Share by Regions 2014-2019
Figure Global Idiopathic Intracranial Hypertension Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Idiopathic Intracranial Hypertension Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Idiopathic Intracranial Hypertension Treatment Market Share by Manufacturers (2014-2019)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Share by Manufacturers in 2018
Table Global Idiopathic Intracranial Hypertension Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Idiopathic Intracranial Hypertension Treatment Product/Solution/Service
Table Date of Enter into Idiopathic Intracranial Hypertension Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Idiopathic Intracranial Hypertension Treatment Market Size Share by Type (2014-2019)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size Market Share by Type (2014-2019)
Table Global Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Idiopathic Intracranial Hypertension Treatment Market Size Share by Application (2014-2019)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size Market Share by Application (2014-2019)
Figure Global Idiopathic Intracranial Hypertension Treatment Revenue Market Share by Application in 2018
Figure United States Idiopathic Intracranial Hypertension Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Idiopathic Intracranial Hypertension Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Idiopathic Intracranial Hypertension Treatment Market Share (2018-2019)
Table United States Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Idiopathic Intracranial Hypertension Treatment Market Share by Type (2014-2019)
Table United States Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Idiopathic Intracranial Hypertension Treatment Market Share by Application (2014-2019)
Figure Europe Idiopathic Intracranial Hypertension Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Idiopathic Intracranial Hypertension Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Idiopathic Intracranial Hypertension Treatment Market Share (2018-2019)
Table Europe Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Idiopathic Intracranial Hypertension Treatment Market Share by Type (2014-2019)
Table Europe Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Idiopathic Intracranial Hypertension Treatment Market Share by Application (2014-2019)
Figure China Idiopathic Intracranial Hypertension Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Idiopathic Intracranial Hypertension Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Idiopathic Intracranial Hypertension Treatment Market Share (2018-2019)
Table China Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-20189) (Million US$)
Table China Idiopathic Intracranial Hypertension Treatment Market Share by Type (2014-2019)
Table China Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019) (Million US$)
Table China Idiopathic Intracranial Hypertension Treatment Market Share by Application (2014-2019)
Figure Japan Idiopathic Intracranial Hypertension Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Idiopathic Intracranial Hypertension Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Idiopathic Intracranial Hypertension Treatment Market Share (2018-2019)
Table Japan Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Idiopathic Intracranial Hypertension Treatment Market Share by Type (2014-2019)
Table Japan Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Idiopathic Intracranial Hypertension Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Idiopathic Intracranial Hypertension Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Idiopathic Intracranial Hypertension Treatment Market Share (2018-2019)
Table Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Share by Type (2014-2019)
Table Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Share by Application (2014-2019)
Figure India Idiopathic Intracranial Hypertension Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Idiopathic Intracranial Hypertension Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Idiopathic Intracranial Hypertension Treatment Market Share (2018-2019)
Table India Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-2019) (Million US$)
Table India Idiopathic Intracranial Hypertension Treatment Market Share by Type (2014-2019)
Table India Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019) (Million US$)
Table India Idiopathic Intracranial Hypertension Treatment Market Share by Application (2014-2019)
Figure Central & South America Idiopathic Intracranial Hypertension Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Idiopathic Intracranial Hypertension Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Idiopathic Intracranial Hypertension Treatment Market Share (2018-2019)
Table Central & South America Idiopathic Intracranial Hypertension Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Idiopathic Intracranial Hypertension Treatment Market Share by Type (2014-2019)
Table Central & South America Idiopathic Intracranial Hypertension Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Idiopathic Intracranial Hypertension Treatment Market Share by Application (2014-2019)
Table Avkare, Inc Company Details
Table Avkare, Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019) (Million US$)
Figure Avkare, Inc Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table Avkare, Inc Recent Development
Table FDC Company Details
Table FDC Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure FDC Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table FDC Recent Development
Table Heritage Pharmaceuticals Inc Company Details
Table Heritage Pharmaceuticals Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure Heritage Pharmaceuticals Inc Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table Heritage Pharmaceuticals Inc Recent Development
Table Ingenus Pharmaceuticals Company Details
Table Ingenus Pharmaceuticals Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure Ingenus Pharmaceuticals Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table Ingenus Pharmaceuticals Recent Development
Table Janssen - Cilag Pharmaceuticals SA Company Details
Table Janssen - Cilag Pharmaceuticals SA Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure Janssen - Cilag Pharmaceuticals SA Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table Janssen - Cilag Pharmaceuticals SA Recent Development
Table Lannett Company, Company Details
Table Lannett Company, Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure Lannett Company, Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table Lannett Company, Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table Medtronic Recent Development
Table MercuryPharma Company Details
Table MercuryPharma Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure MercuryPharma Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table MercuryPharma Recent Development
Table Nostrum Laboratories Inc Company Details
Table Nostrum Laboratories Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure Nostrum Laboratories Inc Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table Nostrum Laboratories Inc Recent Development
Table Novast Holdings Ltd. Company Details
Table Novast Holdings Ltd. Revenue in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)(Million US$)
Figure Novast Holdings Ltd. Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2014-2019)
Table Novast Holdings Ltd. Recent Development
Table Sanofi Company Details
Table SGPharma Pvt. Ltd. Company Details
Table Sophysa Company Details
Table Taro Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd Company Details
Table West-Ward Pharmaceutical Company Details
Table Zydus Pharmaceuticals Company Details
Table Global Idiopathic Intracranial Hypertension Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size Share by Regions (2019-2025)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size Share by Regions in 2025
Figure United States Idiopathic Intracranial Hypertension Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Idiopathic Intracranial Hypertension Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Idiopathic Intracranial Hypertension Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Idiopathic Intracranial Hypertension Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Idiopathic Intracranial Hypertension Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Idiopathic Intracranial Hypertension Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Idiopathic Intracranial Hypertension Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size by Product (2019-2025)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size by Product in 2025
Table Global Idiopathic Intracranial Hypertension Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size by Application (2019-2025)
Figure Global Idiopathic Intracranial Hypertension Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---